Amalgamated Bank Neuronetics, Inc. Transaction History
Amalgamated Bank
- $13.6 Billion
- Q3 2025
A detailed history of Amalgamated Bank transactions in Neuronetics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 1,235 shares of STIM stock, worth $2,679. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,235
Previous 1,235
-0.0%
Holding current value
$2,679
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding STIM
# of Institutions
96Shares Held
19MCall Options Held
49.6KPut Options Held
78.8K-
Vanguard Group Inc Valley Forge, PA2.83MShares$6.15 Million0.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$3.77 Million1.44% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.51MShares$3.27 Million0.01% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.1MShares$2.39 Million1.17% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$2.17 Million0.14% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $58.6M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...